Skip to main content

News

By Susan Morse | 12:20 pm | March 29, 2023
The FDA has approved the first nonprescription OTC naloxone nasal spray, Narcan.
SPONSORED
By Experian Health | 11:56 am | March 29, 2023
Expedite and automate claims processes with AI.
By Jeff Lagasse | 11:46 am | March 29, 2023
Bertolini is a national healthcare thought leader and former chairman and CEO of Aetna.
By Jeff Lagasse | 04:34 pm | March 28, 2023
The AG has alleged that Express Scripts has used its market dominance solely for its financial gain.
By Susan Morse | 12:06 pm | March 28, 2023
CMS has released a proposed rule to speed up prior authorization approval.
By Susan Morse | 11:41 am | March 28, 2023
The acquisition strategically aligns CVS to the ongoing trend of home health for an aging population.
By Jeff Lagasse | 11:35 am | March 28, 2023
Lawmakers said the legislation would offer Medicare beneficiaries acesss to breakthrough medical devices.
By Susan Morse | 12:11 pm | March 27, 2023
Ninety percent rate clinician burnout as a major concern for their provider organizations.
By Susan Morse | 11:16 am | March 27, 2023
Individuals can be assisted, "perhaps even literally while waiting for their clothes to dry," says UPMC for You president.
By Jeff Lagasse | 03:17 pm | March 24, 2023
New IBM Quantum System One is being touted as the first on-site private sector IBM-managed quantum computer in U.S.